New Obesity Definition and Higher Wegovy Dose
Jan 20, 2025•29 min•Ep. 108
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drs. Karl and Spencer chat about the new Lancet Commission's report on Clinical Obesity along with the new study on high dosed Wegovy.
Learn:
How 7.2 mg of Wegovy (semaglutide) compares to 2.4 mg
What the proposed definitions of clinical and preclinical obesity are
Click here to join Dr. Spencer's new online clinic
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android